Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

Similar articles for PubMed (Select 23303781)

1.

Clostridium difficile TcdC protein binds four-stranded G-quadruplex structures.

van Leeuwen HC, Bakker D, Steindel P, Kuijper EJ, Corver J.

Nucleic Acids Res. 2013 Feb 1;41(4):2382-93. doi: 10.1093/nar/gks1448. Epub 2013 Jan 8.

2.

Clostridium difficile toxin synthesis is negatively regulated by TcdC.

Dupuy B, Govind R, Antunes A, Matamouros S.

J Med Microbiol. 2008 Jun;57(Pt 6):685-9. doi: 10.1099/jmm.0.47775-0. Review.

3.

TcdC does not significantly repress toxin expression in Clostridium difficile 630ΔErm.

Bakker D, Smits WK, Kuijper EJ, Corver J.

PLoS One. 2012;7(8):e43247. doi: 10.1371/journal.pone.0043247. Epub 2012 Aug 17.

4.

Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Matamouros S, England P, Dupuy B.

Mol Microbiol. 2007 Jun;64(5):1274-88.

PMID:
17542920
5.

Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.

Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, Johnson S, Gerding DN, Vedantam G.

J Bacteriol. 2010 Oct;192(19):4904-11. doi: 10.1128/JB.00445-10. Epub 2010 Jul 30.

6.

Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile.

Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, von Eichel-Streiber C.

Eur J Biochem. 1997 Mar 15;244(3):735-42.

7.

Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.

Antunes A, Dupuy B.

Methods Mol Biol. 2010;646:93-115. doi: 10.1007/978-1-60327-365-7_7.

PMID:
20597005
8.

C. difficile 630Δerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA.

Rosenbusch KE, Bakker D, Kuijper EJ, Smits WK.

PLoS One. 2012;7(10):e48608. doi: 10.1371/journal.pone.0048608. Epub 2012 Oct 31.

9.

Bacteriophage-mediated toxin gene regulation in Clostridium difficile.

Govind R, Vediyappan G, Rolfe RD, Dupuy B, Fralick JA.

J Virol. 2009 Dec;83(23):12037-45. doi: 10.1128/JVI.01256-09. Epub 2009 Sep 23.

10.

The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile.

Carter GP, Douce GR, Govind R, Howarth PM, Mackin KE, Spencer J, Buckley AM, Antunes A, Kotsanas D, Jenkin GA, Dupuy B, Rood JI, Lyras D.

PLoS Pathog. 2011 Oct;7(10):e1002317. doi: 10.1371/journal.ppat.1002317. Epub 2011 Oct 13.

11.
12.

Evidence that Clostridium difficile TcdC is a membrane-associated protein.

Govind R, Vediyappan G, Rolfe RD, Fralick JA.

J Bacteriol. 2006 May;188(10):3716-20.

13.

Precise manipulation of the Clostridium difficile chromosome reveals a lack of association between the tcdC genotype and toxin production.

Cartman ST, Kelly ML, Heeg D, Heap JT, Minton NP.

Appl Environ Microbiol. 2012 Jul;78(13):4683-90. doi: 10.1128/AEM.00249-12. Epub 2012 Apr 20.

14.

Mechanism of action and epitopes of Clostridium difficile toxin B-neutralizing antibody bezlotoxumab revealed by X-ray crystallography.

Orth P, Xiao L, Hernandez LD, Reichert P, Sheth PR, Beaumont M, Yang X, Murgolo N, Ermakov G, DiNunzio E, Racine F, Karczewski J, Secore S, Ingram RN, Mayhood T, Strickland C, Therien AG.

J Biol Chem. 2014 Jun 27;289(26):18008-21. doi: 10.1074/jbc.M114.560748. Epub 2014 May 12.

PMID:
24821719
15.

tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile.

Curry SR, Marsh JW, Muto CA, O'Leary MM, Pasculle AW, Harrison LH.

J Clin Microbiol. 2007 Jan;45(1):215-21. Epub 2006 Oct 11. Erratum in: J Clin Microbiol. 2007 Jun;45(6):2103.

17.

Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.

Goldenberg SD, French GL.

J Infect. 2011 May;62(5):355-62. doi: 10.1016/j.jinf.2011.03.001. Epub 2011 Mar 21.

PMID:
21396957
18.

Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A.

Murray R, Boyd D, Levett PN, Mulvey MR, Alfa MJ.

BMC Infect Dis. 2009 Jun 28;9:103. doi: 10.1186/1471-2334-9-103.

19.

The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile.

Saujet L, Monot M, Dupuy B, Soutourina O, Martin-Verstraete I.

J Bacteriol. 2011 Jul;193(13):3186-96. doi: 10.1128/JB.00272-11. Epub 2011 May 13.

20.

Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences.

Stabler RA, Dawson LF, Phua LT, Wren BW.

J Med Microbiol. 2008 Jun;57(Pt 6):771-5. doi: 10.1099/jmm.0.47743-0.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk